BIOT
Game-changing Decision: New Genomic Techniques Approved!
📅 On 25.01.2024, AGRI and ENVI Committees agreed to relax rules for NGTs in plant breeding. 🌱 NGT-1 plants exempt from labeling and safety assessment if equivalent to conventional breeds. 🤝 European Parliament and agriculture ministers to vote on modified proposal in February. ❗️ Environmental organizations disappointed with lack of political impact from anti-NGT campaigns.
Breakthrough Technology Solving Cell Therapy Bottleneck
🧬 The emergence of CRISPR-based gene editing has revolutionized cell therapy research. 🔬 However, there is a significant bottleneck in the development and manufacturing of these therapies. ⚙️ Critical to CRISPR-based gene editing is the effective delivery of editing components to target cells. 🔬 Scaling the process for industrial manufacturing is a challenge, especially for therapies that require ex vivo editing of patient cells. ⚡ Electroporation technology, specifically flow electroporation, offers a solution to this bottleneck. 📈 Flow electroporation can transfect billions of cells at a time, providing scalability and process standardization. 💉 This technology is already being used to enable CRISPR-based therapies and has played a critical role in the commercial approval of the first CRISPR-based cell therapy. 🧬 As companies and scientists develop more advanced cellular therapies, flow electroporation will continue to expand access to non-viral approaches. 🌍 While questions remain about the long-term safety and efficacy of genome editing therapies, CRISPR-related technologies offer new avenues for treating diseases.
Boosting Manufacturing Efficiency: AI’s Role in Cutting Costs and Enhancing Therapies
🧪 AI accelerates commercialization strategies by cutting costs and improving processes in advanced therapy manufacturing. 🔬 5 of batches fail, impacting health and revenues. 🧠 AI is crucial for complex therapies. 💰 Manufacturers need to optimize processes and reduce costs. 🌐 AI enables learning transfer and supports decision-making. 📈 Industry 4.0 will use machine learning for real-time predictions and support.
Breaking: Evotec Reports Ex-CEO’s Suspicious Share Trading
🗞️ Insider trading involving the former CEO of Evotec was immediately reported by the company. ⚖️🔍💼
Breakthrough Treatment Prevents Blindness – BlueRock Leads the Way!
💼 Biotechnology company BlueRock aims to prevent blindness by commercializing a groundbreaking ocular disease treatment. 👀🌟
Boosting Machine Learning in Biotech with Prediction Stability
📚 Researchers have developed an approach to improve machine learning in biological sequence design. 👥 By considering prediction stability, the selection pool of antibodies can be expanded. 💡 This method allows machine learning algorithms to identify diverse sequences unrelated to training data. ⚖️ The approach balances safety and success by finding a middle ground between prediction accuracy and uncertainty. 🧪 Scientists validated this approach by designing antibodies against galectin-3 and successfully expressing a desired sequence. 🔬 The researchers used their own multi-objective optimization software, but any off-the-shelf optimizer can be used. 🌐 This approach can be particularly useful in situations with limited data.
AstraZeneca Seeks UK Gov Aid to Boost Vaccine Production
📰 AstraZeneca wants UK Gov aid to expand vaccine plant 💸 The pharmaceutical company seeks financial support to boost production capacity. 💉
Novartis Revolutionizes Cancer Therapy Production with Automation
📢 Novartis automates new radioligand therapy plant in Indianapolis! Increased supply and timely production for prostate cancer therapy. 👨🔬🤖🏭💉
Revolutionary Tech Speeds Up Biotech Cell Line Development
🔍 Abzena launches new tech to speed up cell line development in biotech industry. 🚀 HTSP allows rapid generation and evaluation of high-producing cell lines. 💼 Streamlining processes for biopharma companies. 👩🔬💉
Revolutionizing Bioprocessing with Machine Learning
🤖 Machine learning (ML) reduces guesswork in bioprocessing by improving precision and minimizing errors. Factors like bio-kinetics, bioprocess responses, instrumentation, and environmental disturbances influence outcomes. ML can control bioreactors, identify errors in chromatography analysis, and selecting the right ML algorithm and model is crucial for real-time application. Combining ML-based tools with other analytical methods and correct data maximizes the benefits of ML in bioprocessing.
